GLP-1 Drugs Can Now Be Sold Online by Anyone

Recently, there has been a massive boom in the online sale of drugs known as GLP-1 receptor agonists, which are particularly used for weight loss. These drugs contain active ingredients like semaglutide, which is also used in diabetes treatment, and their popularity has increased rapidly in recent years. However, the sale of these drugs without a prescription or in an unregulated manner brings serious health risks. The fact that anyone can easily open a virtual clinic and sell these drugs, especially on social media platforms and various apps, creates a worrying situation. This situation is considered a result of the unregulated spread of "telehealth", i.e., remote healthcare services.

From dating apps like Grindr to MAGA influencers, a wide spectrum of individuals and organizations can now open online clinics to sell GLP-1 drugs. While this makes the drugs affordable and easily accessible, it also brings serious security issues. Experts warn that such unregulated sales could lead to misuse, dosage errors, and even the introduction of fake drugs into the market. Additionally, it is emphasized that these drugs can have serious side effects and must absolutely be used under a doctor's supervision.

This boom in the online sale of GLP-1 drugs is actually part of a larger trend: a phenomenon called the "Temu experience of telehealth", which promises the rapid and cheap delivery of healthcare services. However, there are serious concerns about the quality and safety of these services. In particular, the competence of healthcare professionals working on such platforms and how rigorous the prescription-writing processes are being questioned. Furthermore, there are risks such as patients' medical histories not being fully evaluated, and drug interactions and underlying health issues being overlooked.

This situation also poses a major challenge for regulatory agencies. Organizations like the U.S. Food and Drug Administration (FDA) are struggling to regulate online drug sales. In particular, tracking and regulating sales made through social media platforms and apps is becoming highly complex. Experts state that stricter regulations and oversight are needed to prevent such sales. Additionally, it is recommended that patients be careful when buying drugs from such platforms and always consult a healthcare professional.

In conclusion, this boom in the online sale of GLP-1 drugs highlights the balance between the opportunities and risks arising from the digitalization of healthcare. On the one hand, access to these drugs becomes easier, while on the other hand, serious health risks emerge. Therefore, it is of great importance that both regulatory agencies and consumers are aware of this issue. In the future, it is expected that such online healthcare services will be subject to stricter regulations and patient safety will be prioritized.